Nebulock, the AI-driven threat hunting platform transforming endpoint security, today announced it has raised $8.5 million in funding, including $6 million in seed funding led by Bain Capital Ventures ...

South Africa’s National Treasury accused the Boston-based firm of engaging in “corrupt and fraudulent practices” related to a ...

US pharma major Bristol Myers Squibb and Bain Capital announced the creation of a new independent biopharmaceutical company ...

(Reuters) -Drugmaker Bristol Myers Squibb and private equity firm Bain Capital will launch an independent company focused on ...

The $139 billion TAMP has hired industry veteran Phil Rogerson, unveils $10 million commitment for strategic expansion in ...

Bristol Myers will get a nearly 20% stake in the startup, which will be led by one of its former executives, Dan Lynch, and ...

The American pharmaceutical company Bristol Myers Squibb, together with the venture capital firm Bain Capital, is forming a ...

Bain & Co. is closing down its consultancy business in Johannesburg, likely bringing to an end a years-long battle to try and ...

BMS is spinning out a new company with five immunology assets, including oral drugs being developed for systemic lupus ...

The biopharma spinoff will advance the development of its five investigational therapies designed to treat autoimmune disease.

France came a distant second to the UK with $694mn across 65 deals, followed closely by Germany with $669mn from 58 deals. “These three markets remain the backbone of Europe’s fintech ecosystem, ...

Bristol Myers Squibb is spinning off a fresh company armed with five autoimmune disease drugs and $300 million in Bain ...